Storia in 2 fonti

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mornings like we had on Wednesday are exactly why I get up and do this show eve...

Raccontata da

markets.businessinsider.com

investorplace.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

markets.businessinsider.comStai leggendo1 mese fa

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

UniQure's stock jumped 81% after FDA green-lighted AMT-130 gene therapy for Huntington's. Early institutional options positioning before catalysts reveals how binary events move biotech—conviction visible in derivatives weeks before market consensus.

originale

investorplace.com1 mese fa

QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now

Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV (QURE) opened around $43. Touched $48.88 intraday. Closed in the high $47s. Previous close:…

Leggi questa versione →

Timeline cronologica

venerdì 19 giugno 2026·markets.businessinsider.com
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mornings like we had on Wednesday are exactly why I get up and do this show eve...
venerdì 19 giugno 2026·investorplace.com
QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now
Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV (QURE) opened around $43. Touched $48.88 intraday.…